Physician
Endocrinology
Dr. Ronald L. Brazg is an expert in the field of Endocrinology. He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACE)". Ronald L. Brazg has written publications. He has 19 publications published with PubMed. The lastest publication is: 'Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B.'
Publications
- Accuracy Evaluation of Contour Next Compared With Five Blood Glucose Monitoring Systems Across a Wide Range of Blood Glucose Concentrations Occurring in a Clinical Res...
- Accuracy of the Enlite 6-Day Glucose Sensor With Guardian and Veo Calibration Algorithms.
- The ASPIRE Study: Design and Methods of an In-Clinic Crossover Trial on the Efficacy of Automatic Insulin Pump Suspension in Exercise-Induced Hypoglycemia.
- Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison With frequent laboratory reference measurements.
- Performance of a new test strip for freestyle blood glucose monitoring systems.
- FreeStyle Navigator Continuous Glucose Monitoring System With TRUstart algorithm, a 1-hour warm-up time.
- Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 Diabetes: a 24-week, multicenter,...
- Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 Diabetes.
- The effect of probucol on HDL-mediated sterol translocation and efflux from cells.
- Psyllium for the reduction of cholestyramine-associated gastrointestinal symptoms in the treatment of primary hypercholesterolemia.
- Efficacy and safety of cerivastatin 0.8 mg in patients With hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group.
- Long-term efficacy and safety of cerivastatin 0.8 mg in patients With primary hypercholesterolemia.
- A dose-ranging study of a new, once-daily, dual-component drug product containing niacin extended-release and lovastatin.
- Recombinant glucagon-like peptide-1 (7-36 amide) lowers fasting serum glucose in a broad spectrum of patients with type 2 Diabetes.
- A continuous glucose sensor based on wired enzyme technology -- results from a 3-day trial in patients with type 1 Diabetes.
- Efficacy, dose-response relationship and safety of once-daily extended-release metformin (Glucophage XR) in Type 2 diabetic patients with inadequate glycaemic control ...
- Insulin excess counteracts the effects of HDL on intracellular sterol accumulation in cultured human skin fibroblasts.
- Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenoType, pattern B.
Schools
University Of The Witwatersrand Faculty Of Health Sciences
Sinai Grace Hospital
University of Washington
Conditions Treated
- Diabetes Type 1
- Diabetes Type 2
- Diabetes With Renal Manifestations
- Hyperlipidemia
- View All
Doctors Specialties
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACE)
Education
-
University of Washington
-
Detroit Medical Center - Wayne State University
-
University of the Witwatersrand
Hospital
-
UW Medicine/Valley Medical Center
Helpful Reviews
Give
Anonymous Review
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.